RE:RE:RE:RE:Biotech Take Over - Wall Street JournalAs background ... the global immune checkpoint inhibitors market size was reported to be US$ 31.4 billion in 2021 and it is expected to hit around US$ 148.1 billion by 2030.
[ Immune Checkpoint Inhibitors are around 15% effective. The intent of having ONCY's pelareorep added to immune checkpoint inhibitors is to increase the effectiveness of both checkpoint inhibitors and pelareorep in a synergistic fashion - with the combination being exponentially effective than either an immune checkpoint inhibitor or pelareorep as a monotherapy. Such a combination of pelareorep + immune checkpoint inhibitor should therefore putatively increase the above market size by 2 to 3 times.]
https://www.precedenceresearch.com/immune-checkpoint-inhibitors-market
Meanwhile the global oncology markt was valued at US$ 286.04 Billion in 2021 and is expected to reach over US$ 581.25 Billion by 2030.
The breast cancer market size in 2021 was US$57.7 Billion.